Cosmos Health
-
Cosmos Health Expands UK Retail Presence with C-Scrub at Superdrug
Cosmos Health is expanding its UK retail presence with the launch of its C-Scrub skincare line in Superdrug stores, the UK’s second-largest health and beauty retailer. This strategic move into over 780 Superdrug locations and online aims to reach a vast consumer base and capitalize on the growing demand for science-backed skincare. The expansion highlights Cosmos Health’s integrated model and its ambition for international growth within the competitive beauty market.
-
Cosmos Health Lands $4.50 Valuation in Zacks Small-Cap Research Debut
Zacks Small-Cap Research initiated coverage on Cosmos Health with a $4.50 price target. They highlight the company’s diversified, vertically integrated model, anticipating strong revenue growth driven by high-margin pharmaceuticals, nutraceuticals, telehealth, and AI R&D. The valuation is based on a five-year DCF analysis, factoring in U.S. market expansion, a $300 million financing facility, and digital asset strategy. Zacks also noted positive recent financial performance.
